Keyword: Vaccines

News

Anergis Expands Management Team

15.02.2013 - Anergis, a company developing breakthrough allergy vaccines for fast and safe allergen-specific immunotherapy, today announced the expansion of its management team. With the...

News

GSK Vaccine Ingredient Scrutinized for Narcolepsy Clues

08.02.2013 - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients...

News

Revived Search for a TB Vaccine May Be About to Pay Off

01.02.2013 - After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year. Global...

News

Evidence Grows for Narcolepsy Link to GlaxoSmithKline's Swine Flu Shot

22.01.2013 - Emelie is plagued by hallucinations and nightmares. When she wakes up, she's often paralysed, unable to breathe properly or call for help. During the day she can barely stay awake...

News

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

19.01.2013 - Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...

News

Roche Says US Allows it to Tap Adult Tamiflu Reserves

18.01.2013 - Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...

News

Hookipa Appoints New Members to Management Team

08.01.2013 - Hookipa Biotech, a vaccine biotech start up pioneering a new class of vaccines, today announced the appointment of two new members to its management team: Thomas P. Monath as Chief...

News

Human Stool Treatment Upends Race to Treat Colon Germ

30.11.2012 - Drugmakers racing to develop medicines and vaccines to combat a germ that ravages the gut and kills thousands have a new challenger: the human stool. For patients hit hardest by...